Rapid RV/LV vs VIDAvision

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Rapid RV/LV

by RapidAI (formerly iSchemaView)

VIDAvision

by VIDA Diagnostics

AI Verdict

Tool A is highly specialized for rapid assessment of pulmonary embolism severity through RV/LV ratio measurements from CTPA scans. In contrast, Tool B provides comprehensive quantitative analysis of chest CTs for a broader spectrum of lung diseases, aiding in diagnosis, monitoring, and treatment planning. While both are FDA-cleared AI tools for chest CT analysis and clinical decision support, their distinct clinical applications make them adjacent rather than direct competitors.

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary need is rapid, AI-powered assessment of pulmonary embolism severity from CTPA scans. This tool is ideal for emergency settings where quick, objective measurement of right and left ventricle ratios is crucial for immediate patient triage and clinical decision-making, aiming to reduce inter-rater variability in acute PE cases.

View Rapid RV/LV →

Choose VIDAvision if…

Choose VIDAvision if you require comprehensive, AI-powered quantitative analysis of chest CT scans for a broad range of chronic lung diseases. This platform is best suited for detailed diagnostic assessment, long-term monitoring, and advanced treatment planning, including applications for bronchoscopy and lung volume reduction, providing deep insights into lung structure and function.

View VIDAvision →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Rapid RV/LV	VIDAvision
Pricing	Contact vendor for pricing information.	Contact for pricing
Deployment	On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall.	Cloud-based (VIDA Intelligence Platform)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid RV/LV

Rapid RV/LV emphasizes 'rapid results (within minutes of scan)' and provides annotated images, suggesting a highly optimized and straightforward user experience for its specific, time-sensitive task of assessing pulmonary embolism severity. Its integration into the broader Rapid platform with workflow and communication tools further streamlines its use in clinical settings.

Clinical Value

VIDAvision

While Rapid RV/LV offers critical, rapid assessment for pulmonary embolism, VIDAvision provides a more comprehensive quantitative analysis across a wider range of lung diseases. It leverages 'AI-powered digital biomarkers' and offers specialized applications for diagnosis, monitoring, and treatment planning, including generating up to 15,000 individual metrics from a single scan.

Pricing & Value

Rapid RV/LV

RapidAI offers a degree of pricing transparency by stating that its pricing for a single module starts at approximately $12,000 in the United States, and clarifies that its annual subscription includes updates, 24/7 support, and training. In contrast, VIDA Diagnostics only specifies 'contact for pricing' and a 'subscription model' without any public figures.

Enterprise Readiness

VIDAvision

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs. However, VIDAvision demonstrates superior enterprise readiness through its extensive list of integrations with major EHRs (Epic, Cerner), PACS systems (GE Healthcare, Philips, McKesson), and cloud platforms. Additionally, VIDA Diagnostics provides detailed certifications for its cloud platform's security and privacy practices, including ISO 13485:2016 and AES256-bit encryption.

Innovation

VIDAvision

While Rapid RV/LV offers focused innovation for rapid PE assessment, VIDAvision demonstrates broader and deeper innovation. It utilizes 'AI-powered digital biomarkers,' comprehensive quantitative CT analysis, 3D reconstruction, and specialized planning applications for various lung diseases, generating a vast array of metrics for detailed pathology characterization.

Support & Docs

Rapid RV/LV

RapidAI explicitly offers 24/7/365 global customer support via email and phone, with technical experts fluent in multiple languages. Their annual subscription includes this live support and access to extensive educational resources, guides, videos, and training sessions. While VIDA Diagnostics also provides customer support and user guides, RapidAI's detailed and explicit commitment to round-the-clock, multi-lingual support is more comprehensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Rapid RV/LV	VIDAvision
Name	Rapid RV/LV	VIDAvision
Company	RapidAI (formerly iSchemaView)	VIDA Diagnostics
Tagline	AI-powered rapid assessment of pulmonary embolism severity.	Clinical Imaging Intelligence
Primary Focus	Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.	Comprehensive quantitative analysis of chest CT scans for the diagnosis, monitoring, and treatment planning of various lung diseases.
Key Feature: AI-powered analysis	AI-powered analysis of CTPA images	AI-powered digital biomarkers
Key Feature: Automated Measurement	Automated measurement of right and left ventricle diameters; Calculation of RV/LV ratio	Automated deep learning-based lung and lobe segmentation; Quantitative CT (QCT) analysis

Videos

Demos, reviews, and walkthroughs featuring Rapid RV/LV and VIDAvision.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and disease states each tool is designed to address?

Rapid RV/LV is specifically designed for the rapid assessment of pulmonary embolism (PE) severity by automatically measuring right and left ventricle ratios from CTPA scans. In contrast, VIDAvision provides comprehensive quantitative analysis of chest CT scans for the diagnosis, monitoring, and treatment planning of various lung diseases, including lung cancer, COPD, and asthma.

What specific quantitative analyses do these tools perform on CT scans?

Rapid RV/LV focuses on AI-powered automated measurement of right and left ventricle diameters and calculation of the RV/LV ratio for PE assessment, providing annotated images. VIDAvision offers broader AI-powered digital biomarkers, automated deep learning-based lung and lobe segmentation, quantitative CT (QCT) analysis, and 3D reconstruction of CT images for detailed quantitative analyses and reports.

How quickly do these tools provide results, and how do they integrate into existing workflows?

Rapid RV/LV provides rapid results within minutes of a CTPA scan, aiming to quickly identify patients with possible right heart strain and reduce time to diagnosis. It integrates with the Rapid PE solution for triage and notification capabilities. VIDAvision delivers detailed quantitative analyses and reports, and includes applications for Lung Bronchoscopy Planning and Lung Volume Reduction, streamlining advanced clinical insights into routine pulmonary workflows.

Do these tools offer capabilities for procedural planning or broader lung disease management?

Rapid RV/LV is specialized for pulmonary embolism severity assessment and integrates with the Rapid PE solution for managing the PE care pathway. VIDAvision, however, provides comprehensive quantitative analysis for various lung diseases and includes specific applications for Lung Bronchoscopy Planning and Lung Volume Reduction, supporting treatment planning.